Advertisement

Topics

Acambis plc Company Profile

09:06 EDT 23rd September 2017 | BioPortfolio

Acambis is a biopharmaceutical company discovering, developing and manufacturing vaccines to prevent and treat infectious diseases. Employing some 160 people, it is based in Cambridge, UK, and Cambridge, Massachusetts. It currently has 11 products in development, of which six are currently undergoing clinical trials, and technology platforms that provide the basis for the development of new products. The products in development include vaccines to prevent Japanese encephalitis, dengue fever, West Nile encephalitis, typhoid, traveller’s diarrhoea and against the stomach-ulcer-causing bacteria, H. pylori. It is also working on a smallpox vaccine for the US Government for the purposes of countering the threat of bioterrorism.

Location

Peterhouse Technology Park, 100 Fulbourn Road
Cambridge
Cambridgeshire
CB1 9PT
United Kingdom

Contact

Phone: +44 (0) 1223 275 300
Fax: +44 (0) 1223 275 300
Email: lyndsay.wright@acambis.com


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study of ChimeriVax™-Japanese Encephalitis Vaccine in Toddlers in Thailand and the Philippines

This study is to assess the safety and immunogenicity of three consecutive lots of JE-CV in toddlers aged 12-18 months. Primary objective: To demonstrate the bio-equivalence of thr...

Companies [4 Associated Companies listed on BioPortfolio]

Acambis

Acambis recognises the value of highly focused marketing efforts and is initially targeting the world's single largest vaccine market – the US – to maximise the return on our investment. In 2003, ...

Acambis plc

Acambis is a biopharmaceutical company discovering, developing and manufacturing vaccines to prevent and treat infectious diseases. Employing some 160 people, it is based in Cambridge, UK, and Cambrid...

Avlar BioVentures Ltd

Avlar was founded in 1999 by Alan Goodman and Daniel Roach and manages Avlar Fund I (£21m) and Avlar Fund II (£43m). Avlar has invested in eighteen companies across a range of sub-sectors of the bio...

Implicit Bioscience

Implicit Bioscience Pty Ltd is an immunology-focused drug development company headquartered in Brisbane, Australia; Implicit's US subsidiary, Implicit Bioscience, Inc., is located on the San Francisco...

More Information about "Acambis plc" on BioPortfolio

We have published hundreds of Acambis plc news stories on BioPortfolio along with dozens of Acambis plc Clinical Trials and PubMed Articles about Acambis plc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Acambis plc Companies in our database. You can also find out about relevant Acambis plc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record